Details
Stereochemistry | ACHIRAL |
Molecular Formula | C7H5ClO2 |
Molecular Weight | 156.566 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
OC(=O)C1=CC=C(Cl)C=C1
InChI
InChIKey=XRHGYUZYPHTUJZ-UHFFFAOYSA-N
InChI=1S/C7H5ClO2/c8-6-3-1-5(2-4-6)7(9)10/h1-4H,(H,9,10)
Molecular Formula | C7H5ClO2 |
Molecular Weight | 156.566 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
p-Chlorobenzoic acid is a major metabolite of analgesic agent zomepirac sodium in rat (present as conjugates) and mouse and a minor one in monkey and man. It is a metabolite of antidepressant Lofepramine hydrochloride, and anxiolytic and a muscle relaxant Chlormezanone too. Sodium salt of p-Chlorobenzoic acid is used as a preservative. p-Chlorobenzoic acid may prove useful clinically to prevent and reverse the accumulation of toxic levels of acyl- and arylCoA esters. If the hepatic damage in Reye’s Syndrome is due to the dead-end formation of the CoA esters of acyl- and aryl-CoA esters, then p-chlorobenzoic acid may block their formation, thereby relieving the inhibitions of gluconeogenesis and urea synthesis and preventing some of the damage to the liver.
Originator
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CoA esters of acyl- and aryl-CoA esters formation Sources: https://www.ncbi.nlm.nih.gov/pubmed/3117062 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Preventing | Unknown Approved UseUnknown |
PubMed
Title | Date | PubMed |
---|---|---|
Comparison of selenium distribution in mice organs after the supplementation with inorganic and organic selenium compound selenosemicarbazide. | 2002 |
|
Novel insights into the interplay between peripheral reactions encoded by xyl genes and the chlorocatechol pathway encoded by tfd genes for the degradation of chlorobenzoates by Ralstonia eutropha JMP134. | 2002 Nov |
|
Use of both 16S rRNA and engineered functional genes with real-time PCR to quantify an engineered, PCB-degrading Rhodococcus in soil. | 2002 Oct |
|
Effects of an inorganic and two new organic compounds of selenium on morphologic blood elements and antioxidant status in mice. | 2003 |
|
The strength of dehalogenase-substrate hydrogen bonding correlates with the rate of Meisenheimer intermediate formation. | 2003 Aug 12 |
|
[A new aerobic gram-positive bacterium with a unique ability to degrade ortho- and para-chlorinated biphenyls]. | 2003 Nov-Dec |
|
Mechanistic implications of the effect of TiO2 accessibility in TiO2-SiO2 coatings upon chlorinated organics photocatalytic removal in water. | 2004 |
|
Bis(micro-4-chlorobenzoato-kappa(2)O:O)bis[(2-aminopyridine-kappaN)silver(I)]. | 2004 Apr |
|
The purification and characterisation of 4-chlorobenzoate:CoA ligase and 4-chlorobenzoyl CoA dehalogenase from Arthrobacter sp. strain TM-1. | 2004 Apr |
|
A QM/MM study of a nucleophilic aromatic substitution reaction catalyzed by 4-chlorobenzoyl-CoA dehalogenase. | 2004 Apr 7 |
|
The Hotdog fold: wrapping up a superfamily of thioesterases and dehydratases. | 2004 Aug 12 |
|
Functional establishment of introduced chlorobenzoate degraders following bioaugmentation with newly activated soil. Enhanced contaminant remediation via activated soil bioaugmentation. | 2004 Feb |
|
Linear correlation between inactivation of E. coli and OH radical concentration in TiO2 photocatalytic disinfection. | 2004 Feb |
|
Biodegradation of DDT by a Pseudomonas species. | 2004 Jan |
|
Effect of Fenton-like oxidation on enhanced oxidative degradation of para-chlorobenzoic acid by ultrasonic irradiation. | 2004 Jul |
|
Chlorobenzoate-degrading bacteria in similar pristine soils exhibit different community structures and population dynamics in response to anthropogenic 2-, 3-, and 4-chlorobenzoate levels. | 2004 Jul |
|
Crystal structure of 4-chlorobenzoate:CoA ligase/synthetase in the unliganded and aryl substrate-bound states. | 2004 Jul 13 |
|
Kinetic decomposition of ozone and para-chlorobenzoic acid (pCBA) during catalytic ozonation. | 2004 May |
|
Photocatalysis of p-chlorobenzoic acid in aqueous solution under irradiation of 254 nm and 185 nm UV light. | 2004 Nov |
|
Development and validation of HPLC method for determination of indomethacin and its two degradation products in topical gel. | 2005 Apr 29 |
|
Analysis of the C-terminal domain of Burkholderia sp. strain LB400 BphK reveals a conserved motif that affects catalytic activity. | 2005 Aug 1 |
|
Pathways and metabolites of microbial degradation of selected acidic pharmaceutical and their occurrence in municipal wastewater treated by a membrane bioreactor. | 2005 Jul |
|
Optical activity induced by helical arrangements of tryptamine and 4-chlorobenzoic acid in their cocrystal. | 2005 Mar 2 |
|
Advanced oxidation effect of ozonation combined with electrolysis. | 2005 Nov |
|
The chemometric resolution and quantification of overlapped peaks form comprehensive two-dimensional liquid chromatography. | 2005 Nov 25 |
|
Screening of organic halogens and identification of chlorinated benzoic acids in carbonaceous meteorites. | 2005 Sep |
|
Effect of long-term exposure, biogenic substrate presence, and electron acceptor conditions on the biodegradation of multiple substituted benzoates and phenolates. | 2005 Sep |
|
Efficiency of activated carbon to transform ozone into *OH radicals: influence of operational parameters. | 2005 Sep |
|
Different net effect of TiO2 sintering temperature on the photocatalytic removal rates of 4-chlorophenol, 4-chlorobenzoic acid and dichloroacetic acid in water. | 2006 |
|
Antiplasmodial and antitrypanosomal activity of new esters and ethers of 4-dialkylaminobicyclo[2.2.2]octan-2-ols. | 2006 Aug |
|
Comparison of the efficiency of *OH radical formation during ozonation and the advanced oxidation processes O3/H2O2 and UV/H2O2. | 2006 Dec |
|
Cometabolic degradation of polychlorinated biphenyls at low temperature by psychrotolerant bacterium Hydrogenophaga sp. IA3-A. | 2006 Jul |
|
Mechanism and pathways of chlorfenapyr photocatalytic degradation in aqueous suspension of TiO2. | 2006 May 15 |
|
Isomorphous crystals of strychninium 4-chlorobenzoate and strychninium 4-nitrobenzoate. | 2006 Sep |
|
Metabolism of 4,4'-dichlorobiphenyl by white-rot fungi Phanerochaete chrysosporium and Phanerochaete sp. MZ142. | 2006 Sep |
|
2,2-Dimethyl-5-nitroso-1,3-dioxan-5-yl benzoate, 2,2-dimethyl-5-nitroso-1,3-dioxan-5-yl 4-chlorobenzoate and 5-nitroso-1,3-dioxan-5-yl 4-chlorobenzoate. | 2007 Jun |
|
Analysis of p-chlorobenzoic acid in water by liquid chromatography-tandem mass spectrometry. | 2007 Sep 14 |
|
Oxidation of p-chlorotoluene and cyclohexene catalysed by polymer-anchored oxovanadium(IV) and copper(II) complexes of amino acid derived tridentate ligands. | 2008 Aug 28 |
|
Structural characterization of a 140 degrees domain movement in the two-step reaction catalyzed by 4-chlorobenzoate:CoA ligase. | 2008 Aug 5 |
|
Structure and denaturation of 4-chlorobenzoyl coenzyme A dehalogenase from Arthrobacter sp. strain TM-1. | 2008 Feb |
|
Diaqua-bis(4-chloro-benzoato-κO)bis-(N,N-diethyl-nicotinamide-κN)manganese(II). | 2008 Feb 29 |
|
FT-IR, FT-Raman spectra and ab initio HF, DFT vibrational analysis of p-chlorobenzoic acid. | 2008 Mar |
|
The effect of electrode material on the generation of oxidants and microbial inactivation in the electrochemical disinfection processes. | 2009 Mar |
|
Synthesis of alpha-amyrin derivatives and their in vivo antihyperglycemic activity. | 2009 Mar |
|
Application of preparative capillary gas chromatography (pcGC), automated structure generation and mutagenicity prediction to improve effect-directed analysis of genotoxicants in a contaminated groundwater. | 2010 May |
|
Photoreactivity of carboxylated single-walled carbon nanotubes in sunlight: reactive oxygen species production in water. | 2010 Sep 1 |
Sample Use Guides
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/3117062
p-Chlorobenzoic acids (1 mM) prevented the inhibition of glucose synthesis in hepatocytes incubated with p-octylbenzoic acid, paminobenzoic acid, or valproic acid.
Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:42:31 GMT 2025
by
admin
on
Mon Mar 31 18:42:31 GMT 2025
|
Record UNII |
IC7888DF4L
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
30747
Created by
admin on Mon Mar 31 18:42:31 GMT 2025 , Edited by admin on Mon Mar 31 18:42:31 GMT 2025
|
PRIMARY | |||
|
DB03728
Created by
admin on Mon Mar 31 18:42:31 GMT 2025 , Edited by admin on Mon Mar 31 18:42:31 GMT 2025
|
PRIMARY | |||
|
4-Chlorobenzoic acid
Created by
admin on Mon Mar 31 18:42:31 GMT 2025 , Edited by admin on Mon Mar 31 18:42:31 GMT 2025
|
PRIMARY | |||
|
6019
Created by
admin on Mon Mar 31 18:42:31 GMT 2025 , Edited by admin on Mon Mar 31 18:42:31 GMT 2025
|
PRIMARY | |||
|
C040768
Created by
admin on Mon Mar 31 18:42:31 GMT 2025 , Edited by admin on Mon Mar 31 18:42:31 GMT 2025
|
PRIMARY | |||
|
IC7888DF4L
Created by
admin on Mon Mar 31 18:42:31 GMT 2025 , Edited by admin on Mon Mar 31 18:42:31 GMT 2025
|
PRIMARY | |||
|
74-11-3
Created by
admin on Mon Mar 31 18:42:31 GMT 2025 , Edited by admin on Mon Mar 31 18:42:31 GMT 2025
|
PRIMARY | |||
|
1112423
Created by
admin on Mon Mar 31 18:42:31 GMT 2025 , Edited by admin on Mon Mar 31 18:42:31 GMT 2025
|
PRIMARY | |||
|
m3396
Created by
admin on Mon Mar 31 18:42:31 GMT 2025 , Edited by admin on Mon Mar 31 18:42:31 GMT 2025
|
PRIMARY | Merck Index | ||
|
DTXSID9024772
Created by
admin on Mon Mar 31 18:42:31 GMT 2025 , Edited by admin on Mon Mar 31 18:42:31 GMT 2025
|
PRIMARY | |||
|
6318
Created by
admin on Mon Mar 31 18:42:31 GMT 2025 , Edited by admin on Mon Mar 31 18:42:31 GMT 2025
|
PRIMARY | |||
|
32738
Created by
admin on Mon Mar 31 18:42:31 GMT 2025 , Edited by admin on Mon Mar 31 18:42:31 GMT 2025
|
PRIMARY | |||
|
200-805-9
Created by
admin on Mon Mar 31 18:42:31 GMT 2025 , Edited by admin on Mon Mar 31 18:42:31 GMT 2025
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> IMPURITY |
The sum of the percentages of indomethacin related compound A and indomethacin related compound B is NMT 0.2%.
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|